Skip to main content
Clinical Trials/IRCT20171115037478N1
IRCT20171115037478N1
Completed
Phase 3

Comparison of Fluoxetine Therapeutic Effects With Duloxetine in patients with IBS with constipation

Zanjan University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Irritable bowel syndrome is a type of constipation.
Sponsor
Zanjan University of Medical Sciences
Enrollment
120
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • new cases of irritable bowel syndrome
  • aged 18\-45
  • constipation predominant symptoms
  • consistent with the criteria Rome2 criteria

Exclusion Criteria

  • patients with night diarrhea
  • patients with weight loss
  • patients with history of GI bleeding
  • patients that use alcohol, drugs and opiums.
  • patients with psychological diseases
  • patients with CNS disorders
  • patients with kidney or liver failure
  • cardica patients

Outcomes

Primary Outcomes

Not specified

Similar Trials